Details for Patent: 10,071,985
✉ Email this page to a colleague
Which drugs does patent 10,071,985 protect, and when does it expire?
Patent 10,071,985 protects SUNLENCA and is included in two NDAs.
This patent has eighty-one patent family members in forty-three countries.
Summary for Patent: 10,071,985
Title: | Therapeutic compounds |
Abstract: | The present disclosure relates to a compound of formula (Ia), (Ib), (IIa), and (IIb): |
Inventor(s): | Graupe Michael, Henry Steven J., Link John O., Rowe Charles William, Saito Roland D., Schroeder Scott D., Stefanidis Dimitrios, Tse Winston C., Zhang Jennifer R. |
Assignee: | Gilead Sciences, Inc. |
Application Number: | US15680041 |
Patent Claim Types: see list of patent claims | More… ↓ |
Drugs Protected by US Patent 10,071,985
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Gilead Sciences Inc | SUNLENCA | lenacapavir sodium | SOLUTION;SUBCUTANEOUS | 215973-001 | Dec 22, 2022 | RX | Yes | Yes | 10,071,985 | ⤷ Subscribe | Y | Y | ⤷ Subscribe | |||
Gilead Sciences Inc | SUNLENCA | lenacapavir sodium | TABLET;ORAL | 215974-001 | Dec 22, 2022 | RX | Yes | Yes | 10,071,985 | ⤷ Subscribe | Y | Y | ⤷ Subscribe | |||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
International Family Members for US Patent 10,071,985
Country | Patent Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
---|---|---|---|---|---|
European Patent Office | 3347352 | ⤷ Subscribe | CA 2022 00052 | Denmark | ⤷ Subscribe |
European Patent Office | 3347352 | ⤷ Subscribe | 301212 | Netherlands | ⤷ Subscribe |
European Patent Office | 3347352 | ⤷ Subscribe | PA2023501 | Lithuania | ⤷ Subscribe |
European Patent Office | 3347352 | ⤷ Subscribe | 122022000082 | Germany | ⤷ Subscribe |
European Patent Office | 3347352 | ⤷ Subscribe | 2022C/561 | Belgium | ⤷ Subscribe |
European Patent Office | 3347352 | ⤷ Subscribe | CR 2022 00052 | Denmark | ⤷ Subscribe |
>Country | >Patent Number | >Estimated Expiration | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration |